SOMIKACIN (Amikacin Sulphate Injection IP)
Potent Aminoglycoside Antibiotic for Severe Bacterial Infections
SOMIKACIN contains Amikacin Sulphate, a highly effective aminoglycoside antibiotic used for the treatment of serious infections caused by susceptible Gram-negative bacteria. It is particularly useful in cases where other antibiotics are ineffective or resistant.
Key Features & Benefits
- Broad-spectrum activity against Gram-negative bacteria
- Effective in treating resistant and hospital-acquired infections
- Rapid bactericidal action by inhibiting protein synthesis
- Suitable for severe and life-threatening infections
- Reliable option when other antibiotics fail
- Proven clinical efficacy in critical care settings
Indications
SOMIKACIN is indicated for the treatment of:
- Severe respiratory tract infections
- Urinary tract infections (UTI)
- Septicemia and bacteremia
- Intra-abdominal infections
- Skin and soft tissue infections
- Bone and joint infections
Dosage & Administration
- Administered via Intramuscular (IM) or Intravenous (IV) route
- Dosage should be as directed by a healthcare professional
- Typically used for short-term therapy (7–10 days) (Mayo Clinic)
Pharmacological Advantages
- Belongs to aminoglycoside class, works by inhibiting bacterial protein synthesis (Mayo Clinic)
- Effective against multi-drug resistant organisms
- Rapid onset with high peak plasma concentration
- Suitable for use in combination therapy for enhanced efficacy
Safety & Tolerability
- Should be used under strict medical supervision
- May require monitoring of kidney function and hearing during therapy (MedlinePlus)
- Well established safety profile when used appropriately
Why Choose SOMIKACIN?
- Trusted antibiotic for serious and resistant infections
- Strong clinical performance in hospital settings
- Effective backup therapy when first-line treatments fail
Packaging
- Available in injectable vial (e.g., 500 mg / 2 ml)
Tagline
Powerful Defense Against Severe Infections